Bioframe Technologiessp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-12-27
Share capital
5,000.00 PLN
Registered address
ul. Władysława Trylińskiego 14/105, 10-683 Olsztyn, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 356 days for 2024).
- 2025not filed
- 202406/07/2026
- 202315/11/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 3.25kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 1.75kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 1.49kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 4.77kMedianUSD 133.19kAverageUSD 3.03m
Industry
- Manufacture of pharmaceutical preparations (21.2)
Authorized Representatives
Tomasz Gabriel Gardian – Management Board Member
Patryk Rurka – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Gabriel Gardianage 45 | 91 | $1,229.07 | 91% |
Marzena Szczygieł | 9 | – | 9% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 28, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $18,714$18,714 | Prezydent Olsztyna |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wstechnologysp. z o.o. | $258,318.71 | wstechnology.pl | ||
| Biodecsp. z o.o. | $115,508.63 | biodec.pl | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Plan Biosp. z o.o. | $3,404.49 | biotrem.pl | ||
| Greenetoxsp. z o.o. | $3,013.95 | greenetox.com | ||
| Passio Human Microbiomesp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| BioencaS.A. | $0.00 | bioenca.pl |
FAQ
The main business activity of Bioframe Technologies focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on December 27, 2022.
The headquarters is located at: ul. Władysława Trylińskiego 14, 10-683 Olsztyn.
The management board includes Tomasz Gabriel Gardian (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from December 27, 2022 to December 31, 2023.
In 2023, the company generated total revenue of $3,808.
Yes, the company recorded a net profit of $130 in 2023.
Last updated: 2026-07-17